focus -WSS

focus

author：fashion 2025-10-01 21:33:37 - browse：9453

Adobe

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal is expected to net Akili’s shareholders $34 million.

Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued the company at about $1 billion. But despite several strategic pivots, including shifting to direct-to-consumer sales, the company failed to build a sustainable business model. Akili in April announced it would wind down its existing commercial operations and focus on a licensing deal with Japanese pharma company Shionogi while it figured out the best path forward.

Akili is just one of many health tech companies that are struggling following an explosion of investor interest in digital health during the Covid-19 pandemic. In the last month alone, Better Therapeutics, another company making digital treatments, sold its assets for an undisclosed amount after failing to build a business around its app for type 2 diabetes, and Cue Health, a diagnostics startup, shut down after funding interest in its Covid-19 tests evaporated.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Stories you might have missed in 2023: health, science, medicine

WSS

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Merck to acquire Harpoon Therapeutics for $680 million

Norman Reedus' Daryl Dixon

TikTok cracks down on users posting about weight loss drugs

Stanford updates investigation of president’s past research

Nonprofit, backed by Microsoft, to certify AI tools in health care

explore

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Trump demands the U.S. pay no more for drugs than other countries … again

At JPM 2024, hospital systems pitch financial strength to investors

Heart attack and stroke risk calculators need revising

Allen Institute goes after foundational questions, CEO Costa says

The high cost of giving birth even with insurance

Researchers separate signal from noise in heart wearable data

Walensky prepares to leave CDC — and Congress — behind

Trump got a 'target letter.' What is one and what does it mean?

What does generative AI mean for health care? We asked experts

Man who had jail sentence commuted by Trump arrested again

entertainment

Life science postdocs should get big pay hike, NIH panel says

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Study suggests new cause of Down syndrome: cells linked to aging

Hospital chaplains balance Covid safety with patients’ spiritual needs

Plane’s emergency slide plummets from sky, hits Chicago home

JPM pitch from hospitals? Revenue streams outside of patient care

Wikipedia

hotspot

focus

focus